MARY BURNELL: Open Payments
NPI 1124416508 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,697 in 80 payments from 13 companies in 2025. Trend: 2023 $2,295 · 2024 $1,667 · 2025 $1,697
Food & beverage: $1,614Education: $83
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $424 |
| Janssen Biotech, Inc. | 20 | $379 |
| UCB, Inc. | 12 | $272 |
| Galderma Laboratories, L.P. | 8 | $158 |
| PFIZER INC. | 5 | $102 |
| Arcutis Biotherapeutics, Inc. | 4 | $93 |
| Novartis Pharmaceuticals Corporation | 4 | $68 |
| Organon LLC | 4 | $46 |
| Amgen Inc. | 2 | $45 |
| LEO Pharma Inc. | 2 | $39 |
Products named: TREMFYA, Bimzelx, SKYRIZI, NEMLUVIO, BOTOX, Zoryve, CIBINQO, COSENTYX.
Industry payments across WA — which companies pay providers there.
